Cytoprotection of the Gastric Mucosa and Eradication Therapy of <i>Helicobacter Pylori</i> Infection: Points of Conjugation
Aim: to present data on the main components of gastric mucosal protection and the possibilities of H. pylori eradication and cytoprotective pharmacotherapy for its restoration.Key points. The various components of the protection system correspond to the pre-epithelial, epithelial and post-epithelial...
Saved in:
Main Authors: | A. S. Trukhmanov, D. E. Rumyantseva, T. L. Lapina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2025-06-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1577 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function
by: Т. L. Lapina, et al.
Published: (2024-01-01) -
The results of the effectiveness of pharmaceutical treatment of chronic gastritis with erosions associated with <i>Helicobacter pylori</i>with azithromycin and amoxicillin in the elderly
by: T. E. Afanasenkova, et al.
Published: (2024-04-01) -
Challenges and Prospects for Eradication of <i>Helicobacter pylori</i>: Targeting Virulence Factors, Metabolism, and Vaccine Innovation
by: Adrian Bakiera, et al.
Published: (2025-06-01) -
The persistence of Epstein-Barr virus in the gastric mucosa in patients with chronic <i>Helicobacter pylori</i>-induced gastritis with gastric erosions and the effect on the course of the disease depending on the therapy
by: E. E. Dubskaya, et al.
Published: (2021-11-01) -
Benefits of Helicobacter pylori Eradication on Extragastric Diseases
by: Tae Jun Kim, et al.
Published: (2021-12-01)